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“Every moral deed and every physical action in a human life are connected in the human 
heart. We will find the true fusion of these parallel and independent phenomena, moral 
events, and physical events, only when we truly learn to understand the configuration of 
the human heart.” 
Peter Selg – The Mystery of the Heart 
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ABSTRACT 
Congenital heart defects (CHDs) are currently the most prevalent form of birth defect in 
the United States. Their combined frequency and severity make necessary a deeper 
understanding of the molecular underpinnings guiding heart formation. The first major 
step in cardiac morphogenesis, cardiac fusion, involves the medial movement of bilateral 
populations of myocardial precursor cells to the embryonic midline, where they merge to 
form the primitive heart tube. Although crucial to subsequent organogenesis, the precise 
mechanisms governing cardiac fusion remain unknown. Previous studies have found that 
a mutation in platelet-derived growth factor receptor alpha (pdgfra), called refuse-to-fuse 
(ref), results in a lack of proper cardiac fusion in both mouse and zebrafish, implying a 
regulatory role for pdgfra in cardiac fusion. However, the specific tissue that pdgfra 
functions within (myocardium, endocardium, or endoderm) remains unknown. This study 
details the creation of two transgenic constructs by means of the Gateway multi-site 
recombination system, Tg(Bact:loxp-BFP-loxp-Ra-2a-mcherry) and Tg(Nkx2.5:Cre-pA) 
for the purpose of elucidating the functional location of pdgfra during cardiac fusion. 
These constructs will allow pdgfra to be expressed in either the myocardium, 
endocardium, or endoderm, in mutant ref embryos. Thus, allowing us to test whether 
pdgfra expression in the myocardium, endocardium, or endoderm, can rescue the ref 
mutant phenotype. In addition to work identifying the functional location of pdgfra, 
another project undertaken during my time in the Bloomekatz lab involved the creation of 
a review chapter, covering the use of zebrafish as a model organism to study CHDs. In 
this endeavor three figures were created, depicting the molecular contractile mechanisms 
in a sarcomere, an example of zebrafish being used to model a genetic disease involving 
the gene titin (ttn), and the physiological similarities shared between humans and 
zebrafish. The review chapter has been accepted and is pending publication. Lastly, my 
work in the Bloomekatz lab involved multiple 3D printing projects to create confocal 
microscope slide holders, a feeding gun apparatus, and gel electrophoresis combs. 
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I. Elucidating the functional tissue location of platelet-derived 
growth factor receptor alpha in cardiac fusion. 
1.0: INTRODUCTION 
The organogenesis of the mature heart is a complex process involving the 
coordinated movement of precursor cells and proper communication with neighboring 
tissues. In the same way that a building cannot be constructed without first laying the 
correct foundation, the mature heart cannot be formed without first completing early 
foundational processes. The serial nature of these processes means that the earliest 
formative steps are of vital importance. Early defects can be compounded throughout the 
remainder of the heart’s formation and cause malformations. One of these early processes 
involves the medial movement of populations of myocardial precursor cells from their 
bilateral locations of specification towards the embryonic midline, where they merge in a 
process termed cardiac fusion (FIGURE 1) [3, 4].   
Cardiac fusion is a crucial first step in the formation of the mature heart, as 
evidenced by the fact that it is evolutionarily conserved in all vertebrates [5]. The process 
begins with two bilateral populations of cardiac precursor cells in the anterior lateral plate 
mesoderm (ALPM). Each population is split into endocardial and myocardial precursors. 
The endocardial precursors move first towards the embryonic midline, followed by the 
medial movement of the myocardial precursor population and the ALPM [6, 7]. During 
their movement to the midline, the myocardial precursors undergo a mesenchymal-to-
epithelial (MET) transition [8, 9]. During this transition cells convert from a 
mesenchymal morphology, without cell-to-cell contacts, to an epithelial morphology, 
exhibiting apical basal polarity and cell-to-cell adhesion [10]. Once migration to the 
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midline and MET has occurred cells form an epithelial ring covered by an endocardial 
sheet. Further development and deformation of this simple structure eventually leads to 
the creation of a two-layered lumen, which gives rise to the primitive heart tube. 
Although the importance of cardiac fusion is clear, the underlying mechanisms 
are unknown. For example, the driver of the movement of the bilateral populations of 
precursor cells to the midline is unknown. Possible answers to these questions could lie in 
the interaction between the mesoderm (the aforementioned myocardial and endocardial 
populations) and the endoderm. Before the migration of either of the mesodermal 
populations, the myocardial precursors are situated laterally to the adjacent endoderm. 
When migration towards the embryonic midline first begins, the endodermal and 
myocardial populations move in a correlated medial manner [12, 13]. However, in the 
later stages of cardiac fusion the cardiac cells migrate underneath the endoderm, at which 
point the movement of the two populations is no longer correlated [12, 13]. The related 
movement of the two populations to the midline, though, suggests a possible role for the 
endoderm during cardiac fusion. Additionally, previous studies have shown that various 
mutations affecting endoderm development and specification result in defects in cardiac 
fusion [14, 15]. The endoderm undoubtedly has a regulatory role in cardiac fusion, but 
the exact nature of that role remains an unanswered question.  
Models have been created, based on correlative studies of endodermal and 
myocardial movement, which indicate three possible regulatory roles for the endoderm 
during cardiac fusion. The first possible role is that of a substrate, in which cardiac cells 
assume an entirely active role and the endoderm functions passively, like a track for the 
myocardial precursors to move along [16]. The second possible role is that of a cytokine 
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provider, in which factors provided by the endoderm are responsible for inducing the 
active movement of myocardial precursors [17]. The final possible role is that of a 
mechanical force, utilizing cytoskeletal contraction to actively pull the myocardial 
precursors to the embryonic midline [13]. Data revealing a novel role for the platelet 
derived growth factor (PDGF) signaling pathway in myocardial precursor movement to 
the midline [18] may help to identify which of these models is correct.  
Platelet-derived growth factors (PDGFs) utilize tyrosine kinase receptors to 
initiate intracellular signaling cascades [19]. These receptor tyrosine kinases (RTKs) have 
been shown to play regulatory roles in a plethora of cellular activities such as cell 
proliferation, survival, adhesion, and differentiation. Furthermore, PDGFs are well 
studied for their roles as directors of mesenchymal cell migration [20]. Notably, PDGF 
signaling through RTKs has been implicated in cardiac organogenesis, including in the 
contribution of cardiac neural crest cells to the outflow tract [21, 22], inflow tract 
formation, [23], and epicardial epithelial-to-mesenchymal transitions (EMTs) leading to 
epicardial derivatives [24]. Furthermore, PDGFs play significant roles in the development 
of congenital heart defects (CHDs). Genetic studies have shown that loss-of-function 
alleles in platelet-derived growth factor receptor alpha (pdgfra) play important roles in 
the development of many CHDs, including ventricular septal defects (VSDs) and total 
anomalous pulmonary venous return (TAPVR) [23, 25].  
Additionally, recent investigations have shown that zebrafish embryos possessing 
a loss-of-function mutation in pdgfra known as refuse-to-fuse (ref) display an early defect 
in heart tube assembly [18]. These ref mutants exhibit a lack of coordinated myocardial 
cell movement during cardiac fusion and ultimately dysmorphic hearts. This early defect 
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suggests that CHDs found in pdgfra mutant embryos could be the result of a disruption of 
proper heart tube formation, as well as later cardiac functions. Moreover, it implies 
that pdgfra plays a significant role in heart tube formation. However, it is unknown which 
tissue pdgfra functions within to regulate heart tube formation.   
Previous studies performed by the Bloomekatz laboratory, using in situ 
hybridization to visualize pdgfra expression in zebrafish embryos, revealed a strong 
pattern of expression in the ALPM [18]. Because the ALPM is where cardiomyocyte 
precursor cells are located, we hypothesize that pdgfra functions within 
cardiomyocyte precursor cells to regulate cardiac fusion. However, it is additionally 
possible that pdgfra is expressed below the level of detection in other tissues, meaning 
that a role for pdgfra could be discovered in the endoderm or the endocardium. This is 
within reason, due to the fact that both tissues have been shown to play a role in cardiac 
fusion [7, 15].  
In order to test our hypothesis and determine the functional tissue location 
of pdgfra, our goal is to express pdgfra in specific tissues in ref mutants and see if the ref 
mutant phenotype is rescued. We are utilizing the Cre/loxP system, which has been 
previously shown to be effective in zebrafish studies [26]. The Cre/loxP system was 
chosen as opposed to the similar Gal4/UAS system because the Gal4/UAS system has 
been shown to be susceptible to epigenetic silencing [27]. Additionally, the Gal4/UAS 
system has been reported to exhibit mosaic expression through plasmid injection, and a 
complete expression is crucial for our purposes [28].  
The Cre/loxP system is a genetic tool used in animal models in order to control 
the expression of a gene, spatially or temporally (FIGURE 2). The system is comprised of 
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two components: a Cre recombinase and loxP recognition sites. In tissues where Cre is 
present it induces recombination at loxP recognition sites, resulting in the excision of 
both the loxP sites and the genetic element they are flanking [29]. Our experiment 
scheme involves four transgenic constructs (FIGURE 3). The first of these transgenic 
constructs contains a ubiquitous promoter (beta actin) which will drive expression of a 
gene in every tissue type, loxP sites flanking a fluorescent marker and stop codon, 
and pdgfra downstream (Figure 6B). In tissues where Cre is selectively expressed, 
recombination occurs between loxP sites, permitting pdgfra to be expressed. The other 
three transgenic constructs allow the tissue-specific expression of Cre. All three are 
comprised of a tissue-specific promoter for either the myocardium (Nkx2.5), 
endocardium (flk1), or endoderm (sox17), upstream of a Cre element. These constructs 
will be used in ref mutants, which inherently have pdgfra expressed in none of their 
tissues, to ensure that pdgfra is expressed only in the desired tissues. As was discovered 
in our previous study, the ref phenotype is characterized by bilateral populations of 
cardiac progenitor cells, or a horseshoe-shaped population of cardiac progenitor cells, 
instead of a ring of cardiomyocytes at the midline. During the assay portion of our 
experimentation, ref mutants carrying the Cre/loxP transgenes will be analyzed using 
fluorescence microscopy and insitu hybridization in order to determine which tissue-
specific Cre-expressing line displays a rescue of the ref phenotype. A complete rescue 
will be characterized by a single, ring-shaped population of cardiac progenitor cells at the 
embryonic midline, as is expected during typical cardiac fusion (FIGURE 4).  
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Figure 1: Schematic of Heart Tube Assembly in Zebrafish 
(A-C) The formation of the heart tube begins with a process termed cardiac fusion. This process begins 
with the medial movement of myocardial and endocardial precursor cell populations towards the 
embryonic midline (A). Endocardial precursor cells begin their medial migration first, followed by the 
myocardial precursor cells. This medial movement is followed by the fusion of the two bilateral 
populations at the midline (B). Following cardiac fusion, deformation and movement of these cells 
gives rise to the heart tube, which all subsequent heart development builds upon (C). (D) Depicts a 
cross-section of the heart fields at the dashed line shown in (B). Endocardial precursor cells, having 
initiated the medial migration, are the medial-most cell type, encompassed by a ring of myocardial 
precursor cells. Both the myocardial and endocardial cells are adjacent to the endoderm, whose specific 
role in driving the process of cardiac fusion remains unknown. Endocardial cells (green), myocardial 
cells (purple), endodermal cells (yellow), outline of developing embryo (black), “s” denotes somites. 
Figure courtesy of Dr. Joshua Bloomekatz. 
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7LVVXH6SHFL¿F3URPRWHU FUH5’ 3’
Cre Recombinase
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Cre recombinase-mediated recombination between loxP sites, excision of EISsegment
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SGJIUD 3’5’ OR[SȕDFW
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3URSHUSGJIUDH[SUHVVLRQLQWKHSURPRWHUVSHFL¿HGWLVVXHW\SH
A.
B.
C.
Figure 2: Cre/LoxP System Overview 
(A) Tissue-specific promoters for either the myocardium, endocardium, or endoderm, ensures Cre 
recombinase (orange rectangle) expression is restricted to those respective tissues. The β-actin 
promoter is ubiquitously stimulated, ensuring that the pdgfra-containing construct is expressed 
throughout all tissue-types. However, the upstream gene, bfp, serves as a fluorescent tag and contains a 
stop codon at its 3’ end, ensuring that in its presence, downstream elements are not be expressed. When 
used in concert with the ubiquitously expressed pdgfra-containing transgene, Cre recombinase catalyzes 
homologous recombination between the loxP sites (B), excising the bfp element and allowing for 
downstream expression of pdgfra (C). 
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LoxP Construct Cre Constructs
Myocardial  
7LVVXH6SHFL¿F
Cre Transgene
Endodermal 
7LVVXH6SHFL¿F
Cre Transgene
Endothelial 
7LVVXH6SHFL¿F
Cre Transgene
ȕact:loxP-BFP-loxP-
Ra-2a-mcherry
A
B
pdgfra expression in only 
the myocardium
pdgfra expression in only 
the endothelium
pdgfra expression in only 
the endoderm
Figure 3: pdgfra Project Overview 
(A-B) Outlines the crossing scheme enabling tissue-specific expression of pdgfra in either the 
myocardium, endocardium, or endoderm.  (A) Four transgenic constructs (depicted here as rectangles) 
are used. One construct Tg(ßact:loxP-BFP-loxP-Ra-2a-mcherry) carries the gene of interest, pdgfra, 
and contains loxP sites flanking a fluorescent gene, bfp. The presence of the loxP-BFP-loxP sequence 
will block downstream expression of pdgfra until Cre recombinase-mediated homologous 
recombination occurs between the loxP sites, due to the stop codon on the 3’ end of the bfp gene. The 
remaining three constructs are Cre-containing, differentiated by their tissue-specific promoters for the 
myocardium (blue), endothelium (green), or endoderm (yellow). This tissue-specificity ensures Cre 
recombinase-mediated homologous recombination occurs only in the tissue of interest. (B) When in the 
presence of the loxP transgene (red), the Cre recombinase produced by each respective cre-containing 
transgene (blue, green, yellow) will result in excision between the loxP sites, removing the bfp gene 
and the tissue specific expression of pdgfra. B-actin (ßact) is a ubiquitously expressed gene whose 
promoter is used to facilitate expression of the loxP transgene in all tissue types. Blue Fluorescent 
Protein (BFP) is a fluorescent protein, which also contains a stop codon on its 3’ end. pdgfra is 
abbreviated as Ra. 2a encodes a short polypeptide that is self-cleaving allowing for the corresponding 
translation mcherry, a fluorescent protein in order to validate proper homologous recombination. 
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A B CRescue Partial-rescueNon-rescue
Figure 4: in-situ Rescue v. No Rescue 
(A-C) Cartoon depictions of what will constitute a rescue after insitu hybridization to identify the 
location of cardiomyocytes in ref mutant embryos exhibiting tissue-specific expression of pdgfra. (A) A 
complete rescue is characterized by a single ring-shaped population of cardiomyocyte precursor cells, 
as is observed in wildtype embryos displaying proper cardiac fusion. No rescue (B) is characterized by 
incomplete ring formation, resulting in a complete lack of cardiac fusion. A partial rescue (C) will be 
characterized by an incomplete ring formation, characterized by a population of cardiomyocyte 
precursor cells that is not fully connected in a ring shape. Areas of high cell density (dark purple), areas 
of low cell density (light purple). Figure adapted from Bloomekatz et al. 2017. 
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1.1 METHODS  
1.1.0: Chemical Bacterial Transformation  
Chemical bacterial transformations insert a plasmid into a competent strain of 
bacteria in order to replicate that plasmid, creating enough amount for use in 
experimentation. To begin, chemically competent E. Coli, (NEB, DH10b, C3019H) are 
thawed on ice from –80oC where they are stored. The cells are then incubated with the 
plasmid of interest in a microcentrifuge tube (on ice, 30 minutes) and exposed to a heat 
shock (45 seconds, 45 oC, using either a heat block or water bath). Following heat shock, 
the cell/DNA mix are incubated while shaking in an antibiotic-free liquid medium (SOC) 
(1.5 hours, 37 oC, 250 rpm), allowing for the expression of the antibiotic resistance gene 
on the plasmid of interest, thus ensuring that the cells containing the plasmid of interest 
are not killed immediately upon introduction to antibiotic. After this, the mix is placed on 
an LB agar plate with the desired antibiotic already mixed in. The presence of the pre-
determined antibiotic ensures that only cells containing the plasmid of interest can grow 
and replicate. After being placed on the plate, the mix is spread using autoclaved glass 
beads. Next, the plates are incubated in a non-shaking incubator (overnight, 37 oC) to 
allow colony growth. 
 
1.1.1: Liquid Culture Inoculation 
Using a cell nutrient broth (liquid LB and agar) in combination with an antibiotic 
(the same as was present on the LB agar plate during transformation), post-
transformation colonies are turned into liquid cultures in order to increase the amount of 
available bacteria. Ejectable pipette tips are utilized in order to pick individual colonies, 
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then placed into individual inoculation tubes. A tube ready for inoculation consists of 1 
colony, 5mL of cell nutrient broth, and the proper amount of antibiotic which varies 
depending on the antibiotic used (kanamycin 50µg/mL, ampicillin 50µg/mL). These 
tubes are designed to be slightly loose when capped to allow for the entrance of oxygen 
into the tube during incubation, which is essential for E. Coli growth. Incubation 
proceeds overnight (37 oC, 250 rpm). Following incubation, tubes in which growth has 
occurred are characterized by a hazy liquid, starkly different from the yellow-clear look 
of LB liquid broth alone. This liquid culture can then be used to make a glycerol stock 
(for storage), or miniprepped (to obtain DNA for use).   
 
1.1.2: Glycerol Stocks 
Glycerol stocks are created so that a working stock of a genetic construct can be 
easily re-created, bypassing the need for a chemical bacterial transformation and 
proceeding directly to the inoculation of a liquid culture. In a microcentrifuge tube, 500 
µL of liquid culture (immediately following inoculation) is mixed with 500 µL of a 
glycerol mixture (50% glycerol, 50% MilliQ water). This mixture is then frozen at –80oC, 
where it can be stably stored for years. When more of the genetic construct is required, all 
that needs be performed is the inoculation of a liquid culture from a stab of the frozen 
glycerol stock.  
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1.1.3: Plasmid Miniprep – DNA Extraction  
The goal of a miniprep is to separate the E. Coli present in the liquid culture from 
their plasmid DNA. Minipreps detailed in this work were performed using 
the ZyppyTM plasmid miniprep kit (Zymo, D4036). 
 
1.1.4: DNA Gel Electrophoresis  
DNA gel electrophoresis separates DNA samples by size by the differential speed 
with which different DNA sized particles move through a gel. Creation of the gel 
involves the mixing of powdered agarose with 1X TBE (a buffer solution containing tris 
base, boric acid, and EDTA), and heating until the agarose is dissolved. After a small 
time of cooling, a small volume (4 µL per 100 ml TBE and agarose) of ethidium bromide 
is added. This ethidium bromide is what allows for later visualization of the DNA bands. 
This is because ethidium bromide is naturally fluorescent when exposed to UV light, and 
fluoresces brighter when bound to DNA. Agarose polysaccharides create a gel matrix-
like structure, through which the DNA moves. The movement of the DNA is facilitated 
by the fact that DNA is a negatively charged molecule. The DNA is loaded into the 
negative end of the gel electrophoresis box, so that when a voltage is applied, the 
molecules run to the positive end. The matrix of gel allows for easier movement of 
smaller molecules, which separates the DNA fragments by size (molecular weight). 
Following the DNA run, the gel is removed from the gel electrophoresis box and placed 
into a UV transilluminator. The ethidium bromide is what is visualized using this 
machine. Because ethidium bromide binds DNA, the DNA fragments are visualized as 
well. A "ladder" is added alongside the DNA fragments of interest, which consists of 
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DNA fragments of known sizes. This ladder is what allows for approximation of the size 
of the DNA fragments in the gel.  
 
1.1.5: Multi-Site Gateway Recombination  
The multi-site Gateway recombination system is a method for assembling 
multiple pieces of DNA together using the process of recombination. We followed the 
protocol from tol2kit.genetics.utah.edu and the lab of A. Untergasser. The LR reaction, 
which adjoins all of the desired genetic elements between the recombination sites and 
discard the other plasmid elements, is performed once all of the entry clones and the 
destination clone have been created or obtained (Figure 5). In the case of both of our 
transgenic Gateway constructs, three entry clones were utilized: a 5’ entry clone (p5E), a 
middle entry clone (pME) and a 3’ entry clone (p3E). The recombination sites in each 
plasmid, termed attachment (att) sites, are specific for other recombination sites, thus 
ensuring the pieces of DNA are recombined in the right order (Table 1). The attL sites 
match the sequence of their corresponding attR sites and no others, allowing for site-
specific recombination upon addition of the proper enzyme (LR clonase II plus) during 
the LR recombination reaction. To begin, the DNA concentration of each clone 
(p5E, pME, p3E, and pDEST) was determined so that each could be diluted to the proper 
concentration (entry clones: 10 fmol, destination clone: 20 fmol). After obtaining the 
proper concentrations, the clones were mixed in a microcentrifuge tube, and the 
LR clonase II plus enzyme added. This mixture was then incubated overnight, followed 
by the addition of proteinase K, which terminates the LR reaction. Once the reaction was 
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stopped, the resulting Gateway DNA constructs were transformed using high competency 
cells.   
 
 
 
 
att
L1 
CAAATAATGATTTTATTTTGACTGATAGTGACCTGTTCGTTGCAACAMA
TTGATGAGCAATGCTTTTTTATAATGCCAACTTTGTACAAAAAAGCAGG
CT 
att
L2 
ACCCAGCTTTCTTGTACAAAGTTGGCATTATAAGAAAGCATTGCTTATC
AATTTGTTGCAACGAACAGGTCACTATCAGTCAAAATAAAATCATTATT
TG 
att
L3 
CAACTTTATTATACAAAGTTGGCATTATAAAAAAGCATTGCTTATCAAT
TTGTTGCAACGAACAGGTCACTATCAGTCAAAATAAAATCATTATTT 
att
L4 
AAATAATGATTTTATTTTGACTGATAGTGACCTGTTCGTTGCAACAAAT
TGATAAGCAATGCTTTTTTATAATGCCAACTTTGTATAGAAAAGTTG 
att
R1 
CAAGTTTGTACAAAAAAGTTGAACGAGAAACGTAAAATGATATAAATA
TCAATATATTAAATTAGATTTTGCATAAAAAACAGACTACATAATACTG
TAAAACACAACATATGCAGTCACTATGAATCAACTACTTAGATGGTATT
AGTGACCTGTA 
att
R2 
TACAGGTCACTAATACCATCTAAGTAGTTGRTTCATAGTGACTGCATAT
GTTGTGTTTTACAGTATTATGTAGTCTGTTTTTTATGCAAAATCTAATTT
AATATATTGATATTTATATCATTTTACGTTTCTCGTTCAACTTTCTTGTA
CAAAGTGG 
att
R3 
CCATAGTGACTGGATATGTTGTGTTTTACAGTATTATGTAGTCTGTTTTT
TATGCAAAATCTAATTTAATATATTGATATTTATATCATTTTACGTTTCT
CGTTCAACTTTATTATACATAGTTG 
att
R4 
CAACTTTGTATAGAAAAGTTGAACGAGAAACGTAAAATGATATAAATA
TCAATATATTAAATTAGATTTTGCATAAAAAACAGACTACATAATACTG
TAAAACACAACATATCCAGTCACTATGG 
 
 
 
Table 1: Att Site Sequences 
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1.1.6: Restriction Enzyme Cloning  
The aim of restriction enzyme cloning is to utilize the ‘sticky’ ends created by 
complementary restriction enzyme digests to insert one piece of DNA (the “insert”) into 
another piece of DNA (the “vector”). This process begins with the PCR isolation of the 
insert. Restriction enzyme sites are added to the ends of the of primers used for PCR so 
that they will be added to the insert upon PCR amplification. These restriction enzyme 
sites match ones present in the vector so that they create complementary overhangs. 
Commercially available vectors contain a multiple cloning site (MCS), consisting of 
multiple restriction enzyme recognition sequences in a small stretch of DNA. This MCS 
allows for a wide range of restriction enzyme options when deciding which to attach to 
one’s insert. Following PCR isolation and restriction enzyme site addition, a gel 
purification step is performed to isolate the amplified DNA from the template DNA. 
Then both the insert amplicon and vector are digested with restriction enzymes. After 
digestions, the linearized vector is treated with a phosphatase enzyme (quick CIP) to 
remove the phosphates from the vector. Therefore, the phosphate used in the ligation 
must come from the insert DNA. This step reduces the number of false positives by 
ensuring that the vector does not re-ligate with itself, due to complementary ends or 
incomplete digestion. After CIP and another round of purification, a ligation reaction is 
performed using T4 DNA ligase and its associated buffer, along with the insert and 
vector DNA segments, at 18 C overnight.   
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Figure 5: Gateway Multi-Site Recombination Schematic 
Attachment (att) sites present on both the entry clones and the destination clone undergo homologous 
recombination in the presence of the proper enzyme mix, LR Clonase II Plus (a blend of integrase, 
integration host factor, excisionase, and reaction buffer). Att sites are genetic sites which are present in 
a specific organization in 5’ entry clones, middle entry clones, 3’ entry clones, and destination clones, 
that have corresponding sequences based on their numbers and letter. L sites match with R sites, and 
corresponding numbered sites match. The homologous recombination at these specific sites results in 
the formation of the final construct, the expression clone, along with the excision of the toxic ccdB gene 
from its position in the destination clone. The excision of the toxic ccdB gene, in combination with 
plating on ampicillin plates, helps to ensure that only colonies with the proper expression clone are able 
to grow. Antibiotic resistances (orange), promoter (yellow), att sites (gray), gene of interest (blue), 3’ 
entry component (pink), tol2 sites (green), toxic ccdB gene (red). 
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1.2: RESULTS  
1.2.0: Tg(Bact:loxp-bfp-loxp-pdgfra-2a-mcherry) 
The first transgenic construct I created was Tg(Bact:loxp-bfp-loxp-ra-2a-mcherry) 
(FIGURE 6b). The function of this construct is to express pdgfra (denoted “Ra” above) 
only in tissues which express Cre, thus facilitating the tissue-specific expression of 
pdgfra. This tissue-specific, Cre-dependent expression occurs through Cre-catalyzed 
recombination between the loxP sites. Before recombination, the gene BFP (blue 
fluorescent protein), blocks the ubiquitous expression of pdgfra, which is downstream. 
To create this transgenic construct we utilized the gateway multisite cloning 
system. The gateway multisite cloning system requires three unique entry vectors (p5E – 
5’ entry, pME – middle entry, p3E – 3’ entry) and a destination vector.   
The middle entry vector contains the gene of interest, in our case pdgfra. 
Although, such plasmid already exists in the lab, the pdgfra gene within this plasmid 
contains a stop codon at its 3’ end, which would block the expression of downstream 
elements via a P2A linker. To create a pME-pdgfra vector without a stop codon, we 
isolated pdgfra using a 3’ cDNA preparation from zebrafish embryos at multiple 
embryonic stages. Following genomic cDNA isolation, primers were designed with the 
threefold purpose of isolating pdgfra, excising the stop codon, and attaching restriction 
enzyme sites to allow restriction enzyme cloning into a vector. Primer design was 
performed using previously published sequence data from Ensembl.org 
(https://useast.ensembl.org/Danio_rerio/Gene/Summary?g=ENSDARG00000070494;r=2
0:22435180-22476255).  Primers were designed to amplify pdgfra without a stop codon, 
attaching SalI and NotI restriction sites on the amplicon. These restriction sites allow 
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pdgfra to be cloned into a pME-empty vector in the correct orientation. Following 
amplification of pdgfra including attachment of the restriction enzyme sites, a gel was 
run to confirm the product was the proper size. Then the band was purified via gel 
purification. Then the pdgfra amplicon and pME empty vector were digested with SalI 
and NotI enzymes. After these double digests, the amplicon and pME vector were 
purified to remove the restriction enzymes and associated buffer, and again run on a 
diagnostic gel (Supplementary Figure S1) to confirm single linear products and to 
estimate DNA concentration.     
Following confirmation that the properly sized pdgfra insert was indeed present, a 
ligation reaction was performed, inserting the pdgfra gene (without its natural stop 
codon) into the empty middle entry vector. A no-insert negative control ligation was also 
performed. After performing the ligation reactions, a chemical bacterial transformation 
was performed in order to isolate fully circular plasmids containing the pdgfra insert. A 
good colony ratio between insert and no insert ligations was achieved. Multiple colonies 
were grown in separate liquid cultures, from which plasmids were isolated via a miniprep 
column kit (Zymo Research). A diagnostic restriction enzyme digest (Supplementary 
Figure S2) was performed on each individual miniprep in order to confirm that the insert 
had been properly inserted into the empty middle entry clone.   
As this middle entry clone contained the gene of interest for this study, it was 
crucial to be certain that no mutations had occurred throughout its creation that would 
alter its protein expression. Due to the fact that processes like PCR can result in small 
mutations in the target region of DNA, which are then exponentially multiplied, it was 
important to take a further confirmation step than a simple diagnostic restriction enzyme 
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digest. Because of this, sequencing primers were designed, and in combination with our 
created pME:Ra sent to Eurofins Genomics in order to be sequenced. Upon receiving the 
sequencing results, it was found that a single nucleotide polymorphism was present in 
the pdgfra sequence of the created pME:Ra. However, because the mutation was silent 
(unaffecting the coded amino acid) it was decided that pME:Ra was complete, and ready 
for the Gateway LR reaction (Supplementary Figure S3).  
The next entry clone required for the creation of the transgenic Gateway construct 
was the 5’ entry clone, p5E:ßact:loxP-BFP-loxP. The ubiquitous nature of the beta-actin 
promoter ensures that when this construct is exposed to one of the tissue-specific Cre 
constructs in either the myocardium, endocardium, or endoderm, pdgfra and other 
downstream components will be expressed. The second important component of this 5’ 
entry clone is BFP, flanked by two loxP recognition sites. BFP is terminated by a stop 
codon, ensuring that nothing downstream of the segment is expressed until the segment is 
excised through Cre-dependent recombination. Lastly, because BFP is present and 
expressed prior to Cre-dependent recombination, it allows for confirmation of transgene 
presence in the animal through fluorescent microscopy (This 5’ middle entry clone was 
graciously sent to us from the lab of Dr. Martin Distel). The plasmid was sent to us on 
sterile filter paper which we soaked in water and used for chemical bacterial 
transformation. DNA isolated from individual colonies was used for a diagnostic 
restriction enzyme digest (Supplementary Figure S4) to confirm the correct plasmid.   
The next required entry clone was the 3’ entry clone, p3E:2a-mcherry. The 
inclusion of the mcherry fluorescent protein allows for confirmation of Cre-dependent 
recombination following the crossing of this Gateway product’s line to one of the tissue-
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specific Cre lines. This line was one of the original lines created for Gateway cloning in 
zebrafish by the Chien lab (now maintained by K. Kwan’s laboratory). In order to create 
a working amount of the clone, a small amount was taken from a previously created 
glycerol stock to inoculate a liquid culture, which was then subjected to DNA isolation 
through a miniprep column kit. From there, a diagnostic restriction digest  was performed 
in order to confirm that the correct clone had been isolated (Supplementary Figure S5).  
The final vector required for the creation of this multisite Gateway product was 
the destination vector, pDESTtol2pA (acquired from K. Kwan at 
tol2kit.genetics.utah.edu). This destination vector was chosen firstly because it provides 
a polyA tail at the most 3’ end of the final construct. The presence of a polyA tail aids 
with mRNA stability and the process of translation. It is important to note that no 
fluorescent protein was necessary to include in this destination vector, due to the fact that 
the combined use of the previously mentioned BFP and mcherry fluorescent proteins 
provide all of the necessary fluorescent microscopy confirmations (confirming both 
initial construct expression and post-Cre-dependent recombination expression).   
Utilizing a previously published protocol from the lab of A. Untergasser, we 
performed the LR recombination reaction using pME:Ra, p5E:Bact:loxP-BFP-loxP, 
p3E:2a-mcherry, and pDEST:tol2pA followed by a chemical bacterial transformation. 
Colonies were selected from the transformation to be made into liquid cultures, which 
were inoculated. A miniprep DNA isolation column kit was then used, and a diagnostic 
restriction enzyme digest performed in order to confirm that the correct product had been 
obtained.  The diagnostic digest returned the correctly sized result. However, it was again 
necessary to perform sequencing on the obtained transgenic construct, as this was the 
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final opportunity to confirm the product before plasmid injection into zebrafish.   
 
1.2.1: Nkx2.5:Cre-pA  
The second transgenic construct I created, Tg(Nkx2.5:Cre-pA), serves the purpose 
of expressing Cre in only myocardial cells (Figure 6a), in order to drive tissue-specific 
expression of pdgfra in the myocardium using the Tg(Bact:loxp-BFP-loxp-Ra-2a-
mcherry) construct we created (see above). The Nkx2.5:Cre-pA construct was also 
created using the Gateway multisite recombination system.  
To create the middle entry clone, pME:Cre, we began with a plasmid already 
present in the Bloomekatz lab, pCR8W-Cre-FRT-kan-FRT. The cre segment of this 
plasmid was amplified and isolated using PCR. Primers for PCR were designed to 
amplify and attach SalI and KpnI restriction enzyme sites on the 5’ and 3’ ends of the 
segment, respectively, thus allowing us to insert the cre amplicon into an empty middle 
entry clone which also contained SalI and KpnI restriction sites. Sequence data for the 
empty middle entry clone was obtained from tol2kit.genetics.utah.edu in order to 
determine the proper sites to use, and ensure that the orientation of the Cre insert would 
be correct upon ligation. Following confirmation that the obtained product was indeed the 
isolated Cre element, a gel DNA purification was performed. Then a pre-ligation 
restriction enzyme digest was then performed on the Cre insert and the pME-empty 
vector, in order to create 5’ and 3’ sticky ends for ligation. Both digested constructs were 
then put through a DNA cleaning and concentration kit, in order to ensure that a high 
enough concentration was present for ligation to occur. Ligation reactions were 
performed both with insert and without insert (negative control). Chemical bacterial 
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transformations of these ligation reactions showed a high ratio of colonies from the insert 
and vector ligation compared to the vector only ligation. DNA isolated from colonies 
from the transformation of the insert and vector ligation, after growth in liquid culture 
and miniprep, were then subjected to a diagnostic restriction enzyme digest 
(Supplementary Figure S6). After confirming clones which had the proper insert 
according to the diagnostic restriction enzyme digest, DNA from these clones were sent 
for sequencing to verify these clones did not contain mutations. Comparing the sequence 
of the clone to previously published Cre sequence data from Ensembl.com, we did not 
find any mutations.   
For the 5’ entry clone, p5E:Nkx2.5 (provided by G. Crump), the promoter 
sequence of Nkx2.5 was chosen due to its well-established role in myocardial cell 
differentiation. For the 3’ entry clone, p3E:pA was chosen in order to afford the construct 
a poly-A tail, which provides additional mRNA stability and aids in translation. The 
destination vector to be used in the final Gateway product, pDEST:Tol2-cryaa-CFP [18] 
was chosen because it contains cyan fluorescent protein (CFP) which is expressed in the 
eye via the alpha-crystallin promoter. This fluorescent tag creates a transgenic mark, 
indicating if a particular fish contains the overall Tg(nkx2.5:cre) transgene. 
The pDEST:Tol2-cryaa-CFP plasmid was previously created by the Bloomekatz lab.  
Similar to our previous efforts in utilizing the gateway system, once having 
created or obtained the 5’ entry (p5E-Nkx2.5promoter), middle entry (pME-cre), 3’ entry 
(p3E-polyA) and destination (pDEST-Tol2-Cryaa:CFP) plasmids, we performed a 
Gateway LR reaction and chemical bacterial transformation. Individual colonies were 
used to inoculate liquid cultures in order to isolate plasmid DNA using a miniprep 
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column kit. Diagnostic restriction enzyme digests were performed on isolated plasmid 
DNA from 6 colonies. in order to confirm that the proper recombination product had 
been obtained. However, we did not identify a correct clone in these colonies. To screen 
through more colonies, we performed colony PCR, eventually identifying a colony that 
had integrated all three plasmids into the destination vector.  
 
 
 
 
 
 
 
 
Tg(nkx2.5:cre)
Tg(ȕactin:loxp-bfp-
loxp-pdgfra-2a-
mcherry)
LR Recombination Sites
Poly-A Tail
cre
nkx2.5
Ampicillin Resistance
LR Recombination Sites
2a-mcherry
pdgfra
ȕDFWLQOR[SEISOR[S
Ampicillin Resistance
A. B.
Figure 6: Gateway Expression Clones - Theoretical Maps 
Theoretical plasmid maps of nkx2.5:Cre-polyA (A) and βactin:loxP-mcherry-loxP-pdgfra-2a-mCherry 
(B). 
   
 
   
 
32 
 
1.3: DISCUSSION 
Through utilization of restriction enzyme cloning and the Gateway recombination 
system, two transgenic constructs were created for use in our project identifying the 
functional location of pdgfra during cardiac fusion. These transgenic constructs, 
Tg(ßact:loxp-BFP-loxp-Ra-2a-mcherry) and Tg(Nkx2.5:Cre-pA), have now been injected 
into zebrafish embryos at the one-cell stage in combination with transposase RNA, to 
begin the process of creating lines of transgenic zebrafish. Once a stable transgenic line is 
isolated for each transgene, the reporter line (Bact:loxp-BFP-loxp-Ra-2a-mcherry) will be 
crossed with each of the three driver lines containing transgenes for tissue-specific 
expression of cre in the myocardium (Nkx2.5:Cre-pA), endocardium, or endoderm. These 
crosses will be performed using ref mutant zebrafish, who normally exhibit an organism-
wide lack of pdgfra expression, thus the only pdgfra expression in these embryos will be 
due to the tissue-specific transgenics. These transgene-containing ref mutant embryos 
will, as previously stated, be analyzed using insitu hybridization in order to determine 
whether tissue-specific expression of pdgfra in the myocardium, endocardium, or 
endoderm results in a rescue of the ref mutant phenotype.  
Upon performing insitu hybridization, we will be able to compare the results to 
our hypothesis that pdgfra functions within cardiomyocyte precursors in order to regulate 
cardiac fusion. There are multiple possible outcomes, each of which will lead to a 
different trajectory of future studies. Firstly, we could, in keeping with our hypothesis, 
find that pdgfra functions within myocardial precursor cells during cardiac fusion, 
signifying a paracrine model of signaling from the endoderm to the myocardium. If this is 
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found to be the case, future studies would be directed towards finding how the tissue-
specific nature of pdgfra is achieved. Alternatively, we could find that pdgfra functions 
within the endoderm during cardiac fusion, signifying an autocrine model of signaling. In 
this scenario, future studies would be directed towards confirming these results through 
endoderm transplantation studies. Lastly, it could be found that none of the transgene-
containing ref mutant embryos exhibit a rescue of the ref phenotype, indicating that 
pdgfra acts in another tissue altogether during cardiac fusion. One possible alternative 
cell type that pdgfra could work within is neural crest cells, in which case future studies 
would be aimed towards obtaining or creating a neural crest-specific Cre line, and 
performing an experiment similar to the one detailed in this study. It is, however, unlikely 
that pdgfra functions within neural crest cells due to the fact that previous studies have 
shown that neural crest cells are not involved in the early formative processes of the heart 
(Richarte et. al 2007, Tallquist & Soriano 2002). 
A future study examining the functional location of pdgf-aa, a Pdgfra ligand, 
would also complement the results of this study. Although previous studies (Bloomekatz 
et. al 2017) have indicated that pdgfaa functions within the endoderm, a study similar to 
this one, in which pdgfaa is expressed in a tissue-specific manner in either the 
myocardium, endocardium, or endoderm, would serve to further support this claim. 
Validating the functional location of pdgfaa would allow a better understanding of the 
PDGF signaling system during cardiac fusion.  
Altogether, the transgenic constructs created through this work will lead to a 
deeper knowledge of the molecular mechanisms employed during PDGF signaling. This 
has the possibility of not only driving future studies of PDGF signaling, but the process 
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of heart formation as a whole. Due to the fact that multiple cardiac diseases are caused by 
an irregularity during cardiac morphogenesis, and cardiac fusion is the first step in this 
complex process, this research has the potential to reveal new information regarding the 
causes and proper treatments of CHDs. 
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II: Aid in the Creation of a Review Chapter: Zebrafish as a 
Model for Congenital Heart Defects (CHDs) 
2.0: INTRODUCTION 
Congenital heart defects are a broad class of defects, grouped because of their key 
similarity: an effect on the structure and functionality of the individual's heart. In the 
United States today, approximately one in every one-hundred live births is affected by a 
CHD. With a rate of incidence this high, CHDs are the most common form of birth defect 
in the United States [1]. Among individuals born with heart defects, one in four will 
require surgery within the first year of life [2]. The combined prevalence and often severe 
nature of CHDs make them a major health issue facing the United States.   
Because of the incidence and severity of CHDs, they have been the topic of study 
for many researchers utilizing zebrafish as a model organism. Zebrafish were elected as 
the model organism for this study for multiple reasons. As is important in any model 
organism, the zebrafish genome displays a high level of molecular conservation with 
humans, meaning that studies performed in zebrafish can be translated to the associated 
human process or disease [30]. In particular, the process of cardiac development and 
cardiac morphology are similar between humans and zebrafish. Additionally, zebrafish 
offer many advantages compared to mice as a model organism. They are small and 
numerous, meaning large numbers can be stored in a single aquatic facility. This, coupled 
with a lower cost of maintenance, makes zebrafish a cost-effective model [31]. Also, 
because zebrafish fertilize externally, embryos are much easier to access for genetic 
techniques, such as plasmid injection at the one-cell stage. Additionally, the embryo is 
transparent meaning that developmental processes can be observed using only a 
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microscope, without the need for parent dissection or interruption of development [32] as 
is required with mice. In addition to these benefits, zebrafish are excellent candidates for 
studies in heart formation, due to the similarities they share with humans. 
Although zebrafish possess a two-chambered heart, the general structure is 
quite similar to a human. Both have a closed cardiovascular system driven by a central 
pumping organ. Additionally, the cardiac chambers of both human and zebrafish consist 
of an inner layer of endocardial cells covered in a layer of muscular myocardial tissue 
[33]. Physiologically, zebrafish and humans are also similar.  Both exhibit similar 
spontaneous beating rates, and a cardiac action potential which is characterized by a long 
plateau phase. Lastly, the contractions of both species’ hearts are regulated by conserved 
ion channels within cardiomyocytes and specialized cells, such as pacemaker cells.  [34, 
35] 
Studies modeling CHDs in zebrafish serve a crucial role, in that they help to 
identify the cellular and molecular mechanisms that guide the formative processes of the 
heart. This means that their results shed light on the causes of what goes wrong in the 
genesis of CHDs. In addition to my work in identifying the functional location of pdgfra, 
I also aided my research advisor, Dr. Joshua Bloomekatz, in drafting a chapter reviewing 
the use of zebrafish in studying the molecular basis of congenital heart defects. This 
review chapter examined the tools that zebrafish researchers used to examine and model 
CHDs, as well as the findings of their associated studies. My work on this project mainly 
consisted of creating multiple figures for use in the chapter. Additionally, part of my 
work in this endeavor involved reviewing, fact-checking, and spell-checking the chapter 
as it neared completion.  
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2.1: RESULTS 
2.1.0: Sarcomere/Cardiomyocyte Figure 
The vital function of the heart, contraction, occurs due to the interaction between 
actin and myosin filaments. However, in order to fully comprehend this seemingly simple 
interaction one must understand the cellular and subcellular structures involved in the 
contraction of the heart. The troponin-tropomyosin complex (consisting of troponin I, 
troponin C, troponin T2, and tropomyosin) attached to actin filament undergoes calcium 
dependent changes which result in the contraction or relaxation of sarcomeres through the 
binding, pulling, and releasing of myosin to actin. At their ends, myosin and actin 
filaments are bound to Z-discs, which serve as connection points between sarcomeres. 
Attached to these Z-discs is titin, a large protein complex which stretches the length of 
the sarcomere and binds myosin, in order to anchor it to the Z disc.  
Multiple CHDs have been found to involve a disruption of sarcomeric genes. 
Previous studies have shown that a mutation of the titin gene (ttn) in zebrafish, 
called pickwick (pik), results in the development of a heart displaying a dilated 
cardiomyopathy (DCM) phenotype. Human patients with a mutation in ttn display similar 
DCM phenotypes. Additionally, a mutation in the zebrafish troponin T type 2a (tnnt2a) 
gene called silent-heart (sih) results in embryos with a variety of phenotypes, including a 
non-contractile heart, pericardial edema, and sparse sarcomere formation. Lastly, 
mutations in the myosin gene have also been studied for their implication in the 
development of CHDs. For example, zebrafish studies have shown that mutations 
in myosin heavy chain 6 (myh6) and myosin heavy chain 7 (myh7) resulted in the 
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development of hypertrophic cardiomyopathy (HCM) and DCM phenotypes. Humans 
with mutations in myh6 and myh7 display similar phenotypes.   
In order to show the complex interplay between all of these components, I created 
a figure depicting a cardiomyocyte at the cellular level, along with an in-depth view of 
the subcellular components of the sarcomere. Additionally, the figure displayed the 
sarcomeric dynamics in the absence, and presence of calcium. Only through 
understanding the components involved in the contraction of the heart is it possible to 
study the effects of their errant expression. This figure (Figure 7) served the purpose of 
providing readers with a visual reference for the multiple interconnected structures 
involved in the dynamic interplay between two cardiomyocytes, which were discussed at 
length in the review in reference to their ability to be causal agents of congenital heart 
defects when improperly expressed.  
 
2.1.1: TTNtv Figure  
In recent studies researchers have observed and researched the intriguing 
phenomenon, that patients exhibiting DCM are more likely to have truncating mutations 
in ttn, titin truncating variants (TTNtvs) at the C-terminus (C-term) of a gene rather than 
the N-terminus. N-terminal (N-term) truncations tend to be less severe. This is intriguing 
due to the fact that a mutation of the N-term (early) should be expected to result in a 
severely truncated protein, and therefore a more severe phenotype than a C-terminal 
(late) truncation. Multiple hypotheses arose as possible answers to this problem. One 
such hypothesis proposed that C-term TTNtvs could result in the formation of a 
dominant-negative mutation. In order to study this hypothesis, researchers went about 
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creating zebrafish models for C-term and N-term TTNtvs. One such study utilized a 
CRISPR/Cas9 and TALEN based approach in order to introduce stop codons (truncating 
agents) in either the N or C-terminus of ttn [11]. This study set out to investigate the 
hypothesis that C-terminal truncations could possibly be creating a dominant-negative 
mutation by creating a double mutation in zebrafish, with both an N and C-term TTNtv. 
These double mutant fish displayed phenotypic similarities to the C-term mutants, 
suggesting that a dominant-negative behavior is unlikely for C-term mutations.  
Another hypothesis tested through zebrafish models proposed that C-
term TTNtvs are simply in exons with higher usage. This hypothesis was generated 
through preliminary studies finding a significant correlation between exon usage 
and TTNtv pathogenicity. Through this study it was discovered that zebrafish TTNtv’s in  
exons known to have high usage rates display more severe phenotypes, which provided 
support for this hypothesis. Ultimately, more studies are required before an explanation 
for this unique finding can be generated.  
In order to display this interesting finding, and the zebrafish studies performed to 
recapitulate and study the dominant-negative hypothesis, I created a figure displaying real 
examples of human and zebrafish TTNtvs. This figure (Figure 8) depicts both N-term 
(early) and C-term (late) mutations of the titin gene in both humans and zebrafish.  
 
 
2.1.2: Human v. Zebrafish AP / Zebrafish ECG Figure  
The reason that studies like that involving the C-term TTNtvs can be studied in 
zebrafish and analyzed alongside human data owes to the striking similarity between 
zebrafish and human cardiac structure and electrophysiology. Similarities in 
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electrophysiology also allow zebrafish researchers to conduct studies regarding cardiac 
conduction defects that can be analyzed in comparison to humans.  
In order to display this striking similarity, I created a figure (Figure 9) depicting a 
human ventricular action potential (AP) as compared to that of a zebrafish, as well as a 
typical zebrafish electrocardiogram (ECG). In both zebrafish and humans, APs begin 
from rest with a rapid depolarization phase and are followed by a slow repolarizing phase 
and finally a rapid repolarizing phase. The only notable difference between the two 
species is that zebrafish lack a distinct early repolarization phase following initial rapid 
depolarization, as is observed in humans. In addition to the similarity in ventricular action 
potential shape, this figure also served to show the shape of a typical zebrafish 
electrocardiogram (ECG or EKG). As with the action potential, the key components of 
the zebrafish ECG resemble very closely those of a human. The coupling of these two 
facts provide an easy-to-grasp benefit of using zebrafish as models to study human 
electrophysiological defects. 
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Figure 7: Cartoon of adjoined Cardiomyocytes and Sarcomere Dynamics 
In the absence of Ca2+ (left cell and inset) the myosin filament (red) is not bound to the actin filament 
(blue), and no contraction occurs. In the presence of Ca2+ (right cell and inset), Ca2+ ions bind troponin 
C (light purple) which pulls tropomyosin (yellow) away from the myosin-binding sites present on actin 
filaments. With binding sites available, the myosin filament binds the actin filament, resulting in cell 
contraction. Both the myosin and actin filaments are bound on their ends to the Z-disc (green). Titin 
(dark purple) extends from one Z-disc through the middle of the myosin filament, meeting and binding 
the end of another titin molecule at the halfway point (the M-line) of the sarcomere. Titin anchors the 
myosin filament at the Z-disc. Figure adapted from Bers et al. 2019, Harvey et al. 2011, Al-Khayat et 
al. 2013, Estigoy et al. 2009. 
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Figure 8: Location of Human Titin Truncating Variants (TTNtvs) and Associated Zebrafish Studies 
(A) Titin truncating variant (TTNtv) mutations (mutations in resulting in an early truncation of the 
translated protein) in human patients with dilated cardiomyopathy (DCM) are more often found in the 
C-terminus of the protein. TTNtv in the N-terminus are often mild or silent. Representative examples 
are shown: A TTNtv (Arg32836X) from a patient with end-stage DCM and a TTNtv (Gln3243X) from 
a healthy individual. (B) Gene editing was utilized to model C-terminal and N-terminal human 
truncations in zebrafish. Also, a mutant was created possessing both N-term and C-term truncations. 
These double mutants display C-terminal truncation phenotypes suggesting that a dominant-negative 
mutation, as hypothesized by Zhou et al., is not made in C-terminal truncations. Arrows (red) indicate 
location of the truncation. Figure adapted from Herman et al. 2012, Roberts et al. 2015, Schafer et al. 
2017, Shih et al. 2016. 
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Figure 9: Zebrafish and Human Ventricular Action Potential (AP) and Zebrafish 
Electrocardiogram (ECG) 
Representative zebrafish and human ventricular action potentials (AP) are depicted (A, B). The 
zebrafish ventricular action potential (A) is similar to the human ventricular action potential (B), 
although it lacks the initial, rapid repolarization that is observed in the human ventricular action 
potential. Also depicted is a typical zebrafish electrocardiogram (ECG) (C) which is also similar to a 
human ECG (not shown), including its distinct P, Q, R, S, and T phases, along with the QT interval. 
Figure adapted from Liu et al. 2016, Poon et al. 2013. 
   
 
   
 
44 
2.2: DISCUSSION 
In summation, my work in the creation of multiple figures, fact-checking, and 
revising helped lead to the completion of a review chapter which will serve as a reference 
of the tools that zebrafish researchers have used, and are currently using to study the 
genesis of CHDs. The first of these highlights the structure of a cardiomyocyte, with an 
added emphasis on sarcomere dynamics and the process of contraction at the sarcomeric 
level.  This figure will help to provide readers with a reference point for future 
discussions regarding the errant function of the components involved. Additionally, I was 
able to depict the interesting finding regarding one gene, titin (ttn). TTNtvs (TTN 
truncating variants) display a more severe phenotype when present on the C-terminus of a 
protein compared to the N-terminus. An important part of this figure was that, while 
originally characterized in humans, zebrafish models have been instrumental in 
deciphering and testing different possible causes. I also sought to create a figure that was 
accessible to readers unfamiliar with genetic mutations or even the difference between 
the C and N-terms of a polypeptide. The third and final figure depicts a human 
ventricular action potential alongside a zebrafish ventricular action potential, along with a 
typical zebrafish ECG. Through a side-by-side comparison of these electrophysiological 
factors, this figure serves to highlight the striking electrophysiological similarities 
between zebrafish and humans. 
My work creating these figures, reviewing, and fact-checking for the review 
chapter, written by the Bloomekatz group, helped lead to the completion of the project as 
a whole. At this point in time, the chapter has been accepted and is pending publication 
[Shrestha, R., Lieberth, J., Tillman, S., Natalizio, J., Bloomekatz, J. (2020) “Using 
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Zebrafish to Analyze the Genetic and Environmental Etiologies of Congenital Heart 
Defects” in Animal Models of Human Birth Defects, Springer Nature, Singapore].  
Upon publication, the review chapter as a whole and the figures to which I 
contributed will hopefully be read and seen by professors, researchers, medical 
professionals, and students. Specifically, I hope the figures that I created will serve as 
visual guides for topics, involving the complexities and advantages of using zebrafish as 
a model organism to study early heart defects, cardiac electrophysiology, TTNtv’s, 
cardiomyocyte structure and function, and the molecular basis for contraction of cardiac 
cells.  
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III: 3D Printing Project 
3.0: INTRODUCTION 
The recent increases in accessibility and affordability of 3D printers now allows 
for the construction of specialized equipment by individual labs, which previously either 
had to be purchased from specialized manufacturing companies at highly marked up 
prices or was unavailable. In particular, the availability of 3D printers in the IDEA 
laboratory in the University of Mississippi (UM) library and the Center for 
Manufacturing Excellence’s (CME) makerspace at UM has allowed us to construct 
several pieces of equipment. In addition to other work performed in the Bloomekatz Lab, 
I was tasked with modeling and printing three pieces of equipment for the lab: confocal 
microscope slide holders, a zebrafish feeding gun apparatus, and a gel electrophoresis 
comb. 
Each project arose from a different combination of functionality and cost. For 
example, the Bloomekatz Lab possessed confocal microscope slide holders prior to my 
joining. However, they were significantly costly, especially considering their simplistic 
design and lack of necessity for being a specific material. On the other hand, the 
zebrafish feeding gun apparatus was something which had never been used in the 
Bloomekatz Lab, nor anything like it. Instead, a scoop system was in use which often left 
tanks being unevenly fed, and notably dirty. The initial desire for the creation of this 
piece of equipment was then out of functionality, to fill a need in the lab through a piece 
of equipment which would improve quality and speed of work. There are feeding 
apparatuses available for sale online, however they are also quite expensive. Lastly, the 
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gel electrophoresis comb project was pursued due to the relatively high cost of this piece 
of equipment, and the ready availability of models. 
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3.1: RESULTS & DISCUSSION 
The first 3D printing project I undertook was creating confocal microscope slide holders. 
In confocal microscopy, samples can be mounted onto glass coverslips in order to be 
visualized. In turn, the glass coverslips are placed onto a slide holder. These items are 
traditionally expensive or even unavailable, even though they have a relatively simple 
geometry, and the material which they are made from is not important for their function 
as a microscope slide holder. Through a simple model and the help of the University of 
Mississippi’s IDEAlab, I was able to create microscope slide holders printable for less 
than a dollar each. The model was designed using Fusion360, free modeling software 
available from Autodesk, and printed using a Lulzbot TAZ 6 3D printer. Polyactic acid 
(PLA) was chosen as a material. Printing was performed using a low infill (5%), due to 
the fact that the slide holder is small and needs to be flat and smooth in order to properly 
hold a microscope slide. Because microscopy is a crucial element in almost all projects in 
the Bloomekatz lab, these slide holders will benefit lab members at a low cost for years to 
come.  
The second 3D printing project I undertook was the creation of a feeding gun. 
Maintenance and upkeep of an aquaculture facility can be incredibly time-consuming and 
take away from time spent in the lab. Normally, food is dispensed using a set of feeding 
scoops of various sizes. This system is laborious and time-consuming, because feeders 
must use three different scoops (a plastic pipette for babies, a “nip” for adolescents, and a 
“smidgen” for adults) and three different food sizes (Gemma micro 75 for babies, 
Gemma micro 150 for adolescents, Gemma micro 300 for adults) (Available from 
Skretting USA). Feeding apparatuses, which speed up the process, are available for 
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purchase from certain companies, but are quite costly. For these reasons, I worked on 
creating a 3D-printed feeding gun apparatus, in order to cut down on the time spent 
during facility-wide feedings, while still delivering the proper amount of food to each 
tank. A model was already available from Marc Tye, from the University of Minnesota 
Twin Cities. This model consists of six individually printed parts: a bottom, handle, lever, 
pivot, slider, and top. Again, the University of Mississippi’s IDEA lab’s TAZ 6 printer 
was used. The parts were printed using PLA at a standard infill of 25%, in order to 
provide a balance between durability and smoothness. All 6 parts have been assembled, 
and the device has been shown to fit a microcentrifuge tube (which is connected to the 
top of the apparatus as to hold the food). However, more customization and optimization 
are needed to make this apparatus functional. This customization includes redesigning the 
dispenser and/or the trigger mechanism to ensure that a consistent amount of food is 
delivered with each pull. Additionally, this will include testing whether the amount of 
food present in the gun’s food storage compartment alters the amount dispensed. Also, 
the overall cleanliness of the tanks following use of the gun, and if the gun is prone to 
food jams, needs to be assessed. Each of these obstacles defeat its intended purpose as a 
time-saving piece of equipment.  
Lastly, I have begun research and work on creating gel combs, for use in DNA gel 
electrophoresis. Similar to these other projects, the cost of purchasing the item from a 
company seemed more expensive than was necessary. Through models available online 
at yeggi.com, a model (https://www.thingiverse.com/thing:352873/files) was selected and 
test printed. However, due to the fact that the gel comb would need to have very smooth 
teeth, in order to ensure the proper running of DNA from the wells it created, a higher 
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quality 3D printer was required. A higher-quality stereolithographic printer from the 
makerspace in the Center for Manufacturing Excellence was used for this reason. While 
the 3D printed gel comb produced had the proper dimensions, it was prone to chipping 
and breaking off of the teeth, meaning that future work towards creating a functional 
product will need to involve optimizing the comb’s dimensions, as well as the material 
used to create it. 
All of the models which I worked on during my time in the lab and notes on their 
creation have been saved, and will be available for future members of the lab to access. 
Through this, the models can be continuously reprinted in the case that more of the 
designed objects are required. Additionally, this ensures that should a future lab member 
wish to continue work on either the feeding gun apparatus or the gel electrophoresis 
comb, they will have all of the resources necessary to do so. 
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A. B. C.
Figure 10: 3D Printing Projects 
Depicted are 3D printed confocal microscope slide holders (A), feeding gun apparatus (B), and gel 
electrophoresis comb (C). (A) was designed from scratch using Fusion 360, and printed at the 
University of Mississippi’s IDEA lab. (B) was created from a design provided by Marc Tye, from the 
University of Minnesota Twin Cities, edited and scaled using Fusion 360, and printed at the University 
of Mississippi’s IDEA lab. (C) was created based on a previous design discovered on the 3D model 
sharing site thingiverse.com (https://www.thingiverse.com/thing:352873/files), edited and scaled using 
Fusion 360, and printed at the University of Mississippi’s Center for Manufacturing Excellence’s 
maker-space. 
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IV: Supplemental Materials 
 
 
  
Figure S1: Gel digest – Pre-digest Ligation of pdgfra and empty middle entry clone 
The pdgfra insert and empty middle entry clone were both double digested prior to their ligation. This 
gel was ran to confirm the size of both of these prior to the ligation reaction.  
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  Figure S2: Gel Digest – pdgfra Ligation 
Following the ligation of pdgfra into the empty middle entry clone, this gel was ran in order to confirm 
proper ligation. Expected product sizes of digested ligation: 3099 bp, 2354 bp. 
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  Figure S3: Sequencing – pdgfra Ligation into Empty Middle Entry Clone 
Following the ligation of pdgfra into the empty middle entry clone, the ligation product was sequenced 
in order to confirm both that the two had been ligated properly and that there were no mutations 
present. The top sequence represents a wildtype pdgfra gene sequence, while the bottom sequence 
represents a sequence selection from the sequenced ligation product. Seen as a red line, there is a 
mutation present in the ligation product at the 491th base pair. This mutation proves to be silent though. 
The wildtype codon, ACT, codes for the same amino acid (threonine) as the mutated form, ACC. 
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Figure S4: Gel Digest: p5E:ßact:loxP-BFP-loxP 
Following transformation of p5E:ßact:loxP-BFP-loxP, a gel digest was ran in order to confirm that the 
received plasmid was the correct one. Expected digested cut sizes: 6788 bp, 4225 bp, 2576 bp, 937 bp. 
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  Figure S5: p3E:2a-mcherry 
Following transformation of p3E:2a-mcherry from the available stock, this digest was ran in order to 
confirm the correct plasmid was indeed present. Expected digested product sizes: 3355 bp, 2528 bp. 
“170”denotes the plasmid p3E:2a-mcherry. 
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  Figure S6: cre Ligation 
Following the ligation of cre into the empty middle entry clone, this gel was ran in order to confirm 
proper ligation. Expected product sizes of digested ligation: 2505 bp, 823 bp. 
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